1 Anniversary of Rick Shea’s departure 2 MNTA/Sandoz appeal Amphastar’s jury verdict. Settlement possible. 3 Shorts covering 4 M281 data expected in 2H 2017 5 M230 – Targeting phase 1 in 2017 6 M293 partnership by Y/E (Word might be out whom their partner is.) 7 Glatopa 40MG FDA approval imminent (I am repeating myself here :-) ) 8 Jbog goes LONG